QuidelOrtho Corp
QDEL
Company Profile
Business description
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
Contact
9975 Summers Ridge Road
San DiegoCA92121
USAT: +1 858 552-1100
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
6,500
Stocks News & Analysis
stocks
ASX listed gold miner under pressure due to lower production
Shares have dropped nearly 20% since lowering 2026 volume guidance.
stocks
3 ASX opportunities after earnings season
Uncovering key opportunities following February’s results.
stocks
Oracle earnings: Solid execution secures revenue target and mitigates investor concerns
We raise our fair value estimate for Oracle stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,826.60 | 6.90 | -0.08% |
| CAC 40 | 7,974.49 | 38.52 | 0.49% |
| DAX 40 | 23,730.92 | 166.91 | 0.71% |
| Dow JONES (US) | 46,993.26 | 46.85 | 0.10% |
| FTSE 100 | 10,403.60 | 85.91 | 0.83% |
| HKSE | 25,868.54 | 34.52 | 0.13% |
| NASDAQ | 22,479.53 | 105.35 | 0.47% |
| Nikkei 225 | 54,485.13 | 784.74 | 1.46% |
| NZX 50 Index | 13,213.07 | 30.84 | 0.23% |
| S&P 500 | 6,716.09 | 16.71 | 0.25% |
| S&P/ASX 200 | 8,619.50 | 6.70 | -0.08% |
| SSE Composite Index | 4,049.91 | 34.88 | -0.85% |